PremiumThe FlyAnavex sees cash runway of four years Anavex management to meet with Maxim AVXL Earnings Report this Week: Is It a Buy, Ahead of Earnings? PremiumThe FlyAnavex announces peer-reviewed publication Phase IIb/III data on blarcamesine Largest borrow rate increases among liquid names Anavex announces 3 years of treatment with blarcamesine show reduced decline PremiumCompany AnnouncementsAnavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability Nordstrom family to take chain private: Morning Buzz Anavex reports Q4 EPS (14c) vs. (12c) last year 
